The relationship between triglyceride-glucose index and albuminuria in United States adults.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 01 05 2023
accepted: 07 08 2023
medline: 11 9 2023
pubmed: 8 9 2023
entrez: 8 9 2023
Statut: epublish

Résumé

Triglyceride-glucose (TyG) index is a simple and reliable indicator of metabolic dysfunction. We aimed to investigate a possible relationship between TyG index and albuminuria in the United States adult population. This cross-sectional study was conducted among adults with complete TyG index and urinary albumin/urinary creatinine (UACR) from 2011-2018 National Health and Nutrition Examination Survey (NHANES). The independent relationship between TyG index and albuminuria (UACR>30mg/g) was evaluated. TyG index was compared with insulin resistance represented by homeostatic model assessment of insulin resistance (HOMA-IR), and metabolic syndrome. Subgroup analysis was also performed. A total of 9872 participants were included in this study, and the average TyG index was 8.53 ± 0.01. The proportion of albuminuria gradually increased with the increase of TyG index quartile interval. Elevated TyG index was independently associated with albuminuria, and this association persisted after additional adjustments for HOMA-IR or dichotomous metabolic syndrome. The area under the ROC curve (AUC) of TyG index was larger than that of log (HOMA-IR). Subgroup analysis suggested that the relationship between TyG index and albuminuria is of greater concern in age<60, overweight/obese, diabetic, and metabolic syndrome patients. The TyG index may be a potential epidemiological tool to quantify the role of metabolic dysfunction, rather than just insulin resistance, in albuminuria in the United States adult population. Further large-scale prospective studies are needed to confirm our findings.

Identifiants

pubmed: 37680883
doi: 10.3389/fendo.2023.1215055
pmc: PMC10482035
doi:

Substances chimiques

Glucose IY9XDZ35W2
Triglycerides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1215055

Informations de copyright

Copyright © 2023 Wang, Qian, Zhong, Gu, Xu and Yang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

JAMA. 2015 Feb 24;313(8):837-46
pubmed: 25710660
Lancet Diabetes Endocrinol. 2020 Feb;8(2):115-124
pubmed: 31879247
Diabetes Care. 2019 Aug;42(8):1569-1573
pubmed: 31182490
Nutr Metab Cardiovasc Dis. 2022 Mar;32(3):596-604
pubmed: 35090800
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1079-88
pubmed: 25887073
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Mar 5;268:120652
pubmed: 34896682
Curr Opin Nephrol Hypertens. 2010 Jul;19(4):379-84
pubmed: 20539231
Cardiovasc Diabetol. 2019 Jul 25;18(1):95
pubmed: 31345238
J Formos Med Assoc. 2018 Aug;117(8):662-675
pubmed: 29486908
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Kidney Int. 2017 Apr;91(4):797-807
pubmed: 28040264
Clin Exp Hypertens. 2023 Dec 31;45(1):2150204
pubmed: 36540929
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11
pubmed: 35529086
Cardiovasc Diabetol. 2021 May 26;20(1):113
pubmed: 34039351
High Blood Press Cardiovasc Prev. 2022 Nov;29(6):547-564
pubmed: 36181637
J Clin Med. 2022 Oct 29;11(21):
pubmed: 36362646
Metab Syndr Relat Disord. 2008 Dec;6(4):299-304
pubmed: 19067533
J Clin Invest. 2018 Apr 2;128(4):1538-1550
pubmed: 29528335
J Clin Med. 2021 Jan 18;10(2):
pubmed: 33477579
Future Cardiol. 2007 Sep;3(5):519-24
pubmed: 19804307
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Hypertens Res. 2023 Feb;46(2):539-541
pubmed: 36474031
Clin Chim Acta. 2013 May;420:76-81
pubmed: 23266772
Clin Chim Acta. 2015 Jun 15;446:111-6
pubmed: 25896961
Chest. 2021 Sep;160(3):1026-1034
pubmed: 33839084
Diabetes Care. 2014 Jun;37(6):1597-603
pubmed: 24623021
Curr Diab Rep. 2003 Feb;3(1):80-6
pubmed: 12643150
Kidney Int. 1998 May;53(5):1343-7
pubmed: 9573550
J Gastroenterol Hepatol. 2007 Mar;22(3):293-303
pubmed: 17295757
Hypertension. 2017 Oct;70(4):687-694
pubmed: 28760941
J Diabetes. 2020 May;12(5):406-416
pubmed: 31769936
Diabetes Res Clin Pract. 2011 Sep;93(3):e98-e100
pubmed: 21665314
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Diabetes Res. 2021 Oct 11;2021:8757996
pubmed: 34671683
Front Immunol. 2022 Mar 21;13:863640
pubmed: 35386695
Clin J Am Soc Nephrol. 2021 Mar 8;16(3):384-395
pubmed: 33619120
Int Urol Nephrol. 2023 May;55(5):1279-1289
pubmed: 36472799
Eur J Gastroenterol Hepatol. 2018 Sep;30(9):986-994
pubmed: 29787418
PLoS Med. 2008 Oct 21;5(10):e207
pubmed: 18942886
Curr Opin Nephrol Hypertens. 2009 Nov;18(6):539-45
pubmed: 19724224
Lipids Health Dis. 2021 Dec 5;20(1):176
pubmed: 34865646
Nephrol Dial Transplant. 2013 Jan;28(1):29-36
pubmed: 23048172
Diabetes Educ. 2017 Apr;43(2):151
pubmed: 28340543
Diabet Med. 2005 Mar;22(3):332-5
pubmed: 15717883
J Clin Endocrinol Metab. 2010 Jul;95(7):3347-51
pubmed: 20484475

Auteurs

Zhaoxiang Wang (Z)

Department of Endocrinology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China.

Han Qian (H)

Department of Cardiology, Affiliated Taicang Hospital of Soochow University, Suzhou, Jiangsu, China.

Shao Zhong (S)

Department of Endocrinology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China.

Tian Gu (T)

Department of Endocrinology, Affiliated Wujin Hospital of Jiangsu University, Changzhou, Jiangsu, China.

Mengjiao Xu (M)

Department of Endocrinology, Affiliated Wujin Hospital of Jiangsu University, Changzhou, Jiangsu, China.

Qichao Yang (Q)

Department of Endocrinology, Affiliated Wujin Hospital of Jiangsu University, Changzhou, Jiangsu, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH